Cancer's Grip and the Quest for Hope: Meet Catherine Rono, a Researcher Fighting Back
Today, we're thrilled to kick off our Early-Career Researcher (ECR) spotlight series, where we'll be showcasing the brilliant minds shaping the future of science. And what better way to start than with Catherine Rono, a postdoctoral researcher at the prestigious Roswell Park Comprehensive Cancer Center, whose work in immunology is nothing short of inspiring.
But here's where it gets personal... Catherine's journey into the world of science wasn't just a career choice; it was a deeply personal mission fueled by the devastating impact of ovarian cancer on her aunt. Witnessing the limited treatment options and the immense suffering, Catherine knew she had to contribute to finding better solutions. This experience became the driving force behind her research, focusing on unraveling the mysteries of disease mechanisms and developing strategies to improve patient outcomes.
And this is the part most people miss... While many are aware of the importance of cancer research, the intricate connection between immunology and metabolism is often overlooked. Catherine's work sits at this fascinating intersection, exploring how targeting metabolic pathways in immune cells can boost the body's ability to fight cancer. Her research aims to enhance the effectiveness of immunotherapies, particularly for cancers like breast cancer, where current treatments fall short.
Catherine's favorite project? She's currently investigating the potential of dendritic cells, the immune system's 'professional' antigen presenters, to improve responses to immune checkpoint inhibitors (ICIs). By targeting the nucleotide synthesis pathway in these cells, she hopes to strengthen their ability to activate cancer-fighting T cells. The exciting part? She's repurposing an existing drug, brequinar, which could accelerate its application in cancer treatment if her studies prove successful.
A Controversial Question: Can We Truly Personalize Cancer Treatment? Catherine's work raises an intriguing point: as we delve deeper into immunometabolism, are we moving closer to tailored therapies that consider individual patient profiles, including their ethnic background? This is especially relevant given her focus on triple-negative breast cancer (TNBC), which disproportionately affects Black and Hispanic women. Her research not only aims to improve treatment outcomes but also to address the racial and ethnic disparities in cancer care.
The most fulfilling aspect of her career so far? Contributing to advancements in TNBC immunotherapy and working closely with patient advocates to ensure community involvement in research. Catherine believes that by incorporating diverse perspectives, we can build trust, improve study design, and promote equitable access to clinical trials.
Now, for a fun twist... If Catherine were a laboratory instrument, she'd be an incubator. Why? Because, just like an incubator provides the perfect environment for growth, she's dedicated to creating spaces where underrepresented individuals can thrive in science. Through mentorship, outreach, and advocacy, she honors the legacy of those who fought for inclusivity in STEM, striving to nurture the next generation of scientists.
As we wrap up, we can't help but wonder: What role do you think community engagement plays in shaping the future of cancer research and treatment? And more importantly, how can we, as a scientific community, better support early-career researchers like Catherine in their quest to make a meaningful impact? We'd love to hear your thoughts in the comments!
Photo Credit: National Cancer Institute, Photographer: John Keith. Source: NCI Visuals Online
